News

AstraZeneca PLC closed 22.84% below its 52-week high of £133.88, which the company achieved on September 3rd.
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) ...
The AstraZeneca PLC ADR AZN rose 1.25% to $68.81 Friday, on what proved to be an all-around positive trading session for the ...
AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that's been reciprocated. The post 21 analysts advised buy AstraZeneca ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...